Neoplasia/BPH

	The diagnostic value of inflammatory markers in bone metastasis of prostate cancer at initial prostate biopsy. Front Oncol Chen X, Li Y, Chen Z, Xie G, Yin H, Li G. PMID: 41142623 [PubMed]
	Clinical features and prognostic analysis of spontaneous rupture of renal cell carcinoma: a retrospective cohort study. Front Oncol Zhang S, Han X, Kong S, Wang J, Wang C, Wu F, Wu H, Lyu J, Ning H. PMID: 41142612 [PubMed]
	Time-Intensity Curve parametric imaging as a novel quantitative biomarker: enhancing diagnostic accuracy and inter-rater reliability in prostate cancer ultrasound. Front Oncol Zhou Y, Liu M, Zhou J, Lin H, Lan J, Xu Y, Yang X, Chen M. PMID: 41142598 [PubMed]
	Malignant solitary fibrous tumor of the kidney with extracapsular extension beyond the renal capsule: An extremely rare Uro-oncological surgical case and diagnostic challenge. Urol Case Rep Naravejsakul K. PMID: 41142189 [PubMed]
	Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial. Eur Urol Open Sci Bernardino RM, Yin LB, Lajkosz K, Winquist E, Cockburn JG, Jenjitranant P, Veloso R, ÓConnell C, Benitez AM, Nguyen DD, Matthiesen R, Henrique R, Joshua AM, van der Kwast T, Fleshner NE. PMID: 41142038 [PubMed]
	Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24). Eur Urol Open Sci Stellato M, Sepe P, Bronte E, Conteduca V, Rocca MC, Giorgi U, Di Napoli M, Galli L, Incorvaia L, Lalli L, Maiorano BA, Maruzzo M, Mennitto A, Roviello G, Santoni M, Sorarù M, Zanardi E, Zucali P, Procopio G, Verzoni E, Meet-URO group. PMID: 41142037 [PubMed]
	Impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in paediatric renal tumours: a SIOP-RTSG radiotherapy committee study. Clin Transl Radiat Oncol Ding M, Maspero M, Harrabi S, Jouglar E, Vennarini S, Spencer T, Weber B, Magelssen H, Van Beek K, Stoica R, Saldi S, Boterberg T, Melchior P, van den Heuvel-Eibrink MM, Janssens GO. PMID: 41141653 [PubMed]
	Critically Important Cancer Outcomes to Report in Kidney Transplant Trials. Kidney Int Rep Dobrijevic E, van Zwieten A, Jaure A, von Huben A, Howell M, Teixeira-Pinto A, Acuna SA, Ahn C, Blosser CD, Craig JC, Davidson B, Francis A, Jhaveri KD, Malyszko J, Newell KA, Mena-Gutierrez A, Murakami N, Scholes-Robertson N, Tedesco Silva H, Wong G. PMID: 41141521 [PubMed]
	A Systematic Literature Review of Real-World Treatment Effectiveness and Economic and Humanistic Burden in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy. Clinicoecon Outcomes Res Shih V, Yin L, Theodorou E, Dillon R, Brancato SJ, Hamilton L, Wirtz HS. PMID: 41141362 [PubMed]
	Influence of renal function on the clinical efficacy of carboplatin plus pemetrexed in patients with non-small cell lung cancer. Nagoya J Med Sci Komeda K, Hase T, Hara T, Kimura T, Kojima E, Abe T, Horio Y, Goto Y, Ushijima F, Watanabe S, Yamada Y, Shimokata T, Oguri T, Yamamoto M, Yanagisawa K, Ando M, Kondo M, Hasegawa Y, Ishii M. PMID: 41140827 [PubMed - indexed for MEDLINE]
	Editorial Comment on Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial. Int J Urol Urabe F. PMID: 41139864 [PubMed - as supplied by publisher]
	Comparing quality of life after robot assisted versus open radical cystectomy: A systematic review. J Robot Surg Hawkins DA, Camacho M, Godbole G, Dell'Oro C, Ewool K, Karim MR, Patel B. PMID: 41139731 [PubMed - indexed for MEDLINE]
	Re: Siamak Daneshmand, Michiel S. Van der Heijden, Joseph M. Jacob, et al. TAR-200 for Bacillus Calmette-GuÃ©rin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: Results from the Phase IIb SunRISe-1 Study. J Clin Oncol. In press. https://doi.org/10.1200/jco-25-01651. Eur Urol Focus Montorsi F, Moschini M, Rosiello G, Gandaglia G, Briganti A. PMID: 41139573 [PubMed - as supplied by publisher]
	A Systematic Review and Meta-Analysis of the Effectiveness and Safety of Immune Checkpoint Inhibitors in Patients With BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer Soliman A, Murad MR, Jabrieh G, AlEdani EM, Saeed A, Belabaci Z, Ghanm TIE, Qutob IA. PMID: 41139553 [PubMed - as supplied by publisher]
	Improvement of postoperative health in prostate cancer patients by puerarin combined with prostatectomy. Pak J Pharm Sci Wang G, Shang L. PMID: 41139249 [PubMed - indexed for MEDLINE]
	Assessing the relationship between cardiometabolic diseases and the risk of developing aggressive prostate cancer: a systematic review and meta-analysis. BMC Cancer Amirmokri AJ, Loffredo CA, Makambi KH, Dawson NA. PMID: 41139205 [PubMed - indexed for MEDLINE]
	Development and external validation of a FISH-clinical nomogram for predicting overall survival in bladder cancer patients after radical cystectomy. BMC Cancer Zheng J, Lu S, Zhang Q, Zhang L, Huang Y, Kong J, Chen X, Zhang J, Yao Y, Luo Y, Lin T. PMID: 41139203 [PubMed - indexed for MEDLINE]
	Letter to the Editor Regarding "Assessing the Influence of Bladder Cancer on Upper Tract Urothelial Carcinoma Prognoses Following Radical Nephroureterectomy: A Retrospective, Propensity Score-Based Multicenter Cohort Study". Ann Surg Oncol Zhu X, Liao D, Huang S, Feng Y, Huang Q, Zhuang Z. PMID: 41139186 [PubMed - as supplied by publisher]
	Stereotactic ablative body radiotherapy for PSMA-PET/CT staged, oligometastatic prostate cancer - A multi-centre study. Radiother Oncol Schupak I, Chao M, Guerrieri M, Ho H, Udovicich C, Ong WL, Starmans M, Tacey M, Foroudi F, Joon DL, Ng M. PMID: 41138859 [PubMed - as supplied by publisher]
	Radiobiological Modeling for Acute Proctitis after Conventional and Hypofractionated Radiotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys Jongen CA, Heijmen BJ, Incrocci L, Heemsbergen WD. PMID: 41138787 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180484

Page 1 of 9025



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy